Home / Denmark / Aquaporin A/S
Aquaporin A/S
Short position disclosed on January 16, 2026.
1.51% of the capital sold short
1 disclosing funds
7 disclosures on record
DK0061555109 ISIN code
Funds holding Aquaporin A/S Titelia
Evolution of the disclosed total
0%0.5%1%1.5%2%
Oct 2025Jan 2026Apr 2026Jul 2026
April 17, 2024 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Guevoura Fund Limited | 1.51% | new | January 16, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| January 16, 2026 | Guevoura Fund Limited | 1.51% | still open |
| January 15, 2026 | Guevoura Fund Limited | 1.37% | January 15, 2026 |
| January 14, 2026 | Guevoura Fund Limited | 1.28% | January 14, 2026 |
| January 12, 2026 | Guevoura Fund Limited | 1.10% | January 12, 2026 |
| January 7, 2026 | Guevoura Fund Limited | 0.81% | January 7, 2026 |
| April 30, 2024 | ExodusPoint Capital Management, LP | 0.00% | April 30, 2024 |
| April 17, 2024 | ExodusPoint Capital Management, LP | 0.50% | April 17, 2024 |
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
- Coloplast A/S 0.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Aquaporin A/S, source Finanstilsynet, data as at January 16, 2026, https://www.quivad.com/action/aquaporin-a-s